Evolution Petroleum's recent production and operating costs have aligned with prior expectations, with dividend coverage estimated at 1.0x. While the company aims to maintain its dividend, its sustainability remains uncertain. Evolution has prioritized near-term production and free cash flow through minor transactions, focusing less on inventory that may take longer to develop. This approach reflects a cautious strategy amid fluctuating oil prices and market conditions.
The global AI in Pathology market, valued at $28.75 million in 2025, is projected to grow at a 9.12% CAGR to reach $68.81 million by 2035. Growth is driven by rising demand for digital pathology, AI diagnostics, and improved workflow efficiency throu...
The global AI data center market is rapidly expanding due to the rise of generative AI and advanced cognitive analytics, requiring purpose-built, high-density facilities with advanced cooling and networking technologies. Hyperscalers like Microsoft, ...
SKYRIZI achieved blockbuster sales of $11.7 billion in 2024, growing 51% year-over-year, driven by approvals in psoriasis, psoriatic arthritis, and inflammatory bowel diseases like Crohn's. Its strong clinical efficacy targeting the IL-23 pathway and...
The global photodynamic therapy (PDT) market is forecasted to grow from $749 million in 2023 to $1.53 billion by 2035, at a CAGR of 8.3%. Growth is fueled by PDT's minimally invasive nature and expanding applications in oncology, dermatology, and ant...
The cancer metabolism-based therapeutics market is projected to grow from $3.7 billion in 2026 to $26.3 billion by 2035, with a CAGR of 24.3%. This growth is fueled by advances in precision medicine targeting unique cancer cell metabolic pathways, in...
